ReviewInternational journal of molecular sciences2026
Risk Assessment and Prediction of Hepatocellular Carcinoma in Noncirrhotic Metabolic Dysfunction-Associated Steatotic Liver Disease.
Emilie K Mitten et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.